Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Blog
  • Understanding the...

Understanding the Scope of Biosimilars in India with Dr. Manish Adhia

Dr. Manish AdhiaWritten by Dr. Manish Adhia Published On 2022-08-02T11:12:08+05:30  |  Updated On 2 Aug 2022 11:12 AM IST
Understanding the Scope of Biosimilars in India with Dr. Manish Adhia
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

The pharmaceutical industry globally is seeing a major shift from small molecules (chemical entity drugs) to the more complex biologics and biosimilars (protein based large molecules.

In fact, biologics account for nearly 12 of the top selling 20 global brands. This is largely attributed to the significantly superior outcomes post treatment with biologics and biosimilars. There has been a significant change in trend of disease incidence – non communicable and chronic life style diseases like Diabetes, Auto immune disorders and cancers are today the major cause of morbidity and mortality. With a population of over 135 crore people and disease trends similar to that of developed economies, India represents a huge opportunity for biosimilars. With a majority of population not covered by any reimbursement plan India remains largely an Out-Of-Pocket (OOP) market wherein most patients have to fund their own treatment costs. In such a scenario the role of Biosimilars assumes immense significance.

The concept of biosimilars is based on their affordability vis-à-vis the innovator biologics and therefore price becomes a key factor in the Indian context. This potential is further augmented by significant acceptance of biologics and biosimilars not only by the treating physicians' but also by the patients as evident by the enhanced compliance for biologics and biosimilars

The first biosimilar was approved in India in the year 2000 by the Indian Drug Authorities. This number has since significantly increased to 98 biosimilars being approved till September 2019 (source: CDSCO). Approvals of biosimilars in regulated markets like Europe and USA has led to keen interest in the Indian pharma companies motivating many of them to invest in this lucrative and growing biosimilars market to improve their footprints in geographies beyond India. Indian companies like Biocon, Intas, Cadila and Reliance have been at the forefront of development and commercialization of biosimilars. These companies have developed in-house product development capabilities. More than 10 blockbuster biologics are set to lose their patents in the next couple of years. The current net revenues of these innovator biologic brands exceeds USD 60bn. This would provide a further boost to the huge potential for Biosimilars in the coming years.

The main factors leading to the high commercial potential and the need for development of indigenous biosimilars in India can be enumerated as under:

1. Large patient pool and high incidence of diseases like diabetes, rheumatoid arthritis and cancers

2. Robust regulatory environment – in 2016 the Indian government framed comprehensive guidelines for development and approval of biosimilars in India under the aegis of CDSCO. The revised regulatory pathways has made the process of application and approvals of biosimilars much more easier to comply with safety, efficacy and quality of the product.

3. Technology – India today has development and manufacturing infrastructure which meets global standards. The Indian government has encouraged and incentivized investments in this area.

4. Access – With rapid improvements in transportation, cold chain logistics and better patient access in remote areas the access to newer treatments like biologics and biosimilars in India is expected to rise exponentially.

5. Government initiatives like the National Biopharma Mission and the Atal Incubation programs has been a significant growth driver of this sector

Globally the biosimilars market is forecasted to reach US $240 billion by 2030. The biosimilars market in India is estimated to grow at a compounded annual growth rate (CAGR) of 22% to become USD 12bn by 2025. This would represent almost 20% of the total pharmaceutical market in India.

Thus the future for biosimilars in India promises to be quite bright and is expected to improve disease outcomes leading to substantial improvements in quality of life and productivity

Disclaimer: The views expressed in this article are of the author and not of the Medical Dialogues. The Editorial/Content team at Medical Dialogues has not contributed to the writing/editing/packaging of this article.

Biosimilarsscope of biosimilars
Dr. Manish Adhia
Dr. Manish Adhia

    Dr. Manish Adhia is an Associate Professor in Management at SVKM's NMIMS Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management. He has done a Ph.D. in Market Access in Pharmaceuticals and has earlier worked as Marketing Head in Hospital Anti-infectives at Pfizer India ltd..

    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    High Blood Pressure in Children Tied to Mothers Pregnancy Health: NIH Study Finds

    High Blood Pressure in Children Tied to Mother's Pregnancy Health: NIH Study Finds

    View All

    Health News Today

    Health Bulletin 10/ May/ 2025

    Health Bulletin 10/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok